
Stryker Achieves $6 Billion in Sales and 227% Free Cash Flow Surge
Stryker CorporationDescription
What this story covers
Stryker reported Q1 2026 net sales of $6.0 billion, driven by 2.4% organic growth. While adjusted margins faced pressure from investments, the company achieved a 227% increase in free cash flow and significantly reduced debt by $1 billion.
Story snapshot
CompanyStryker Corporation
TickerSYK
VariantStandard detailed
Duration5:46
Filing type8-K
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0000310764-26-000025
Sources1
Full Story Script
Content not available for this story.